Stay updated with breaking news from With Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Announced Agreement With Nimbus Therapeutics in December to Acquire a Potential Best-in-Class TYK2 Inhibitor, and with HUTCHMED in January to In-license Highly Selective, Oral Tyrosine Kinase Inhibitor
Announced Agreement With Nimbus Therapeutics in December to Acquire a Potential Best-in-Class TYK2 Inhibitor, and with HUTCHMED in January to In-license Highly Selective, Oral Tyrosine Kinase... | February 2, 2023
With Phase 4 in the books, all eyes turn toward the Marvel movies that will start to fill out Phase 5 in 2023. The year is sparse regarding theatrical releases
Nikola posted a net loss of $236.2 million and reported revenues of $24.2 million in Q3 2022—both improvements over Wall Street analysts' expectations.
With Phase II of highly anticipated Memory Care now full, Phase III has just started taking reservations to accommodate the growing demand for the person-centered dementia care at Frank Residences.